Literature DB >> 11171040

Study of the structure-activity relationships for the pyrazinamidase (PncA) from Mycobacterium tuberculosis.

N Lemaitre1, I Callebaut, F Frenois, V Jarlier, W Sougakoff.   

Abstract

In an attempt to investigate the molecular basis of pyrazinamide hydrolysis by the PncA protein from Mycobacterium tuberculosis, we determined the pyrazinamidase activity of nine PncA mutants bearing a single amino acid substitution. Among them, three mutants (D8G, K96T and S104R) had virtually no activity (< or =0.004 unit/mg), five (F13S, T61P, P69L, Y103S and A146V) retained a low level of activity (0.06-0.25 unit/mg) and one (T167L) exhibited a wild-type activity (1.51 units/mg). The possible structural effects of these substitutions were assessed by analysing a three-dimensional model of the PncA protein constructed on the basis of the crystal structure of the N-carbamoylsarcosine amidohydrolase (CSHase) from Arthrobacter sp., an amidohydrolase which was found by hydrophobic cluster analysis to be closely related to PncA. In the PncA model, five of the mutated residues, Asp-8, Phe-13, Lys-96, Tyr-103 and Ser-104, were located within a 6 A sphere around the cysteine residue Cys-138, which could be the counterpart of the active cysteine residue Cys-177 found in the CSHase. Among the remaining mutated residues, Thr-61, Pro-69 and Ala-146 were found to be more distant from Cys-138 but were associated with structural elements contributing to the catalytic centre, whereas Thr-167 was situated in an alpha-helix located far from the putative active site. These data suggest that the decrease in pyrazinamidase activity observed in the PncA mutant proteins is well correlated with the structural modifications the mutations can cause in the environment of the putative active cysteine Cys-138.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11171040      PMCID: PMC1221589          DOI: 10.1042/0264-6021:3530453

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  Relationship between pyrazinamide resistance, loss of pyrazinamidase activity, and mutations in the pncA locus in multidrug-resistant clinical isolates of Mycobacterium tuberculosis.

Authors:  M Mestdagh; P A Fonteyne; L Realini; R Rossau; G Jannes; W Mijs; K A De Smet; F Portaels; E Van den Eeckhout
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

2.  Crystal structure analysis, refinement and enzymatic reaction mechanism of N-carbamoylsarcosine amidohydrolase from Arthrobacter sp. at 2.0 A resolution.

Authors:  M J Romão; D Turk; F X Gomis-Rüth; R Huber; G Schumacher; H Möllering; L Rüssmann
Journal:  J Mol Biol       Date:  1992-08-20       Impact factor: 5.469

3.  Detection of secondary structure elements in proteins by hydrophobic cluster analysis.

Authors:  S Woodcock; J P Mornon; B Henrissat
Journal:  Protein Eng       Date:  1992-10

4.  Stereochemical quality of protein structure coordinates.

Authors:  A L Morris; M W MacArthur; E G Hutchinson; J M Thornton
Journal:  Proteins       Date:  1992-04

5.  ProMod and Swiss-Model: Internet-based tools for automated comparative protein modelling.

Authors:  M C Peitsch
Journal:  Biochem Soc Trans       Date:  1996-02       Impact factor: 5.407

6.  The human EBNA-2 coactivator p100: multidomain organization and relationship to the staphylococcal nuclease fold and to the tudor protein involved in Drosophila melanogaster development.

Authors:  I Callebaut; J P Mornon
Journal:  Biochem J       Date:  1997-01-01       Impact factor: 3.857

7.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

Authors:  H C Birnboim; J Doly
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

8.  Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis.

Authors:  A Scorpio; P Lindholm-Levy; L Heifets; R Gilman; S Siddiqi; M Cynamon; Y Zhang
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

9.  Crystallographic and fluorescence studies of ligand binding to N-carbamoylsarcosine amidohydrolase from Arthrobacter sp.

Authors:  A Zajc; M J Romão; B Turk; R Huber
Journal:  J Mol Biol       Date:  1996-10-25       Impact factor: 5.469

10.  Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus.

Authors:  A Scorpio; Y Zhang
Journal:  Nat Med       Date:  1996-06       Impact factor: 53.440

View more
  22 in total

Review 1.  Drug-resistance in Mycobacterium tuberculosis: where we stand.

Authors:  Amanda Mabhula; Vinayak Singh
Journal:  Medchemcomm       Date:  2019-06-11       Impact factor: 3.597

2.  Pyrazinamide Is a Two-Edged Sword: Do WHO Guidelines Matter?

Authors:  Kwok-Chiu Chang; Wing-Wai Yew; Ying Zhang
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

3.  Density functional and molecular docking studies towards investigating the role of single-wall carbon nanotubes as nanocarrier for loading and delivery of pyrazinamide antitubercular drug onto pncA protein.

Authors:  Nabanita Saikia; Sanchaita Rajkhowa; Ramesh C Deka
Journal:  J Comput Aided Mol Des       Date:  2013-02-15       Impact factor: 3.686

4.  High-resolution crystal structures of Streptococcus pneumoniae nicotinamidase with trapped intermediates provide insights into the catalytic mechanism and inhibition by aldehydes .

Authors:  Jarrod B French; Yana Cen; Anthony A Sauve; Steven E Ealick
Journal:  Biochemistry       Date:  2010-09-20       Impact factor: 3.162

5.  Role of metal ions on the activity of Mycobacterium tuberculosis pyrazinamidase.

Authors:  Patricia Sheen; Patricia Ferrer; Robert H Gilman; Gina Christiansen; Paola Moreno-Román; Andrés H Gutiérrez; Jun Sotelo; Wilfredo Evangelista; Patricia Fuentes; Daniel Rueda; Myra Flores; Paula Olivera; José Solis; Alessandro Pesaresi; Doriano Lamba; Mirko Zimic
Journal:  Am J Trop Med Hyg       Date:  2012-07       Impact factor: 2.345

6.  Peruvian and globally reported amino acid substitutions on the Mycobacterium tuberculosis pyrazinamidase suggest a conserved pattern of mutations associated to pyrazinamide resistance.

Authors:  Mirko Zimic; Patricia Sheen; Miguel Quiliano; Andrés Gutierrez; Robert H Gilman
Journal:  Infect Genet Evol       Date:  2009-12-04       Impact factor: 3.342

7.  Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand.

Authors:  Jirarut Jonmalung; Therdsak Prammananan; Manoon Leechawengwongs; Angkana Chaiprasert
Journal:  BMC Microbiol       Date:  2010-08-20       Impact factor: 3.605

8.  Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from Korea and analysis of the correlation between the mutations and pyrazinamidase activity.

Authors:  Jee-Hyun Yoon; Ji-Sun Nam; Kyung-Jin Kim; Young-Tae Ro
Journal:  World J Microbiol Biotechnol       Date:  2014-07-18       Impact factor: 3.312

9.  Effect of pyrazinamidase activity on pyrazinamide resistance in Mycobacterium tuberculosis.

Authors:  Patricia Sheen; Patricia Ferrer; Robert H Gilman; Jon López-Llano; Patricia Fuentes; Eddy Valencia; Mirko J Zimic
Journal:  Tuberculosis (Edinb)       Date:  2009-02-26       Impact factor: 3.131

10.  Insight to pyrazinamide resistance in Mycobacterium tuberculosis by molecular docking.

Authors:  Amirudeen Nusrath Unissa; Nagamiah Selvakumar; Sameer Hassan
Journal:  Bioinformation       Date:  2009-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.